$CBIO
Crescent Biopharma, Inc., an oncology company, develops therapies for cancer patients. Its pipeline includes a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates to treat solid tumors. The company is headquartered in Waltham, Massachusetts.
Healthcare
Sector
Biotechnology
Industry
Joshua T. Brumm
CEO
33
Employees
$16.89
Current Price
$260.41M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 7 | 9 | $285,500.96 | 16,726 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 7 | 9 | $285,500.96 | 16,726 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | Lynch Ryan Treasurer, Senior Vice President of Finance and Chief Accounting Officer. | Sale | 240 | $17.90 | $4,296.00 | View Details |
| Sep 16, 2026 | Pinkas Jan Chief Scientific Officer | Sale | 658 | $17.90 | $11,778.20 | View Details |
| Sep 16, 2026 | Im Ellie Eunkyung Chief Medical Officer | Sale | 623 | $17.90 | $11,151.70 | View Details |
| Sep 16, 2026 | Scalzo Richard William Chief Financial Officer | Sale | 568 | $17.90 | $10,167.20 | View Details |
| Sep 16, 2026 | Bispham Barbara Harlin General Counsel and Corporate Secretary. | Sale | 620 | $17.90 | $11,098.00 | View Details |
| Sep 16, 2026 | Brumm Joshua T Director | Sale | 1,610 | $17.90 | $28,819.00 | View Details |
| Sep 18, 2026 | Brumm Joshua T Director | Sale | 7,837 | $16.71 | $130,956.27 | View Details |
| Sep 16, 2026 | McNeill Jonathan President and COO | Sale | 731 | $17.90 | $13,084.90 | View Details |
| Sep 18, 2026 | McNeill Jonathan President and COO | Sale | 3,839 | $16.71 | $64,149.69 | View Details |
9 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
EPS
Estimated-$0.67
ActualN/A
Revenue
Estimated$357.14K
ActualN/A
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: